Rallybio Presents Natural History Study for Fetal and Neonatal Alloimmune Thrombocytopenia at the 65
-- FNAIT Natural History Study to Inform Frequency of FNAIT Risk in a Broad and Diverse Population of Pregnant Women ---- Study Designed to Provide a Contemporary Control Dataset to Support a Future Registrational Trial in Pregnant Women --NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a cli...
Source: pharmiweb.com